Menu
Menu
Oncology News Today brings you all the latest news and developments in the world of immunotherapy
A new AI test can pick out which men with high-risk prostate cancer that has not spread will require life-extending...
An immunotherapy helps patients live years longer without their cancer getting worse or coming back, a major phase III trial...
A new study, co-led by Leukaemia UK and Wellcome funded researcher Dr Konstantinos Tzelepis at the Cambridge Stem Cell Institute,...
Opdivo® (nivolumab) in combination with Yervoy® (ipilimumab) has been granted an indication extension in the UK by the MHRA1,2 and...
An immunotherapy treatment helps patients live years longer without their cancer getting worse or coming back, a major phase III...
This January, 100+ world-leading specialists in spatial biology will come together in San Diego for the premier industry-led event dedicated...
To gain access to our entire site, simply click the button below and register.
